References
1. Hammer MJ, Casper C, Gooley TA, O’Donnell PV, Boeckh M, Hirsch IB.
The contribution of malglycemia to mortality among allogeneic
hematopoietic cell transplant recipients. Biol Blood Marrow
Transplant. 2009;15(3):344-351.
2. Storey S, Von Ah D. Impact of malglycemia on clinical outcomes in
hospitalized patients with cancer: a review of the literature.Oncol Nurs Forum. 2012;39(5):458-465.
3. Sopfe J, Pyle L, Keating AK, et al. Malglycemia is associated with
poor outcomes in pediatric and adolescent hematopoietic stem cell
transplant patients. Blood Adv. 2019;3(3):350-359.
4. Rodbard D. The challenges of measuring glycemic variability.Journal of diabetes science and technology. 2012;6(3):712-715.
5. Monnier L, Colette C, Wojtusciszyn A, et al. Toward Defining the
Threshold Between Low and High Glucose Variability in Diabetes.Diabetes Care. 2017;40(7):832-838.
6. Kovatchev B, Cobelli C. Glucose Variability: Timing, Risk Analysis,
and Relationship to Hypoglycemia in Diabetes. Diabetes care.2016;39(4):502-510.
7. Danne T, Nimri R, Battelino T, et al. International Consensus on Use
of Continuous Glucose Monitoring. Diabetes care.2017;40(12):1631-1640.
8. Salkind SJ, Huizenga R, Fonda SJ, Walker MS, Vigersky RA. Glycemic
variability in nondiabetic morbidly obese persons: results of an
observational study and review of the literature. J Diabetes Sci
Technol. 2014;8(5):1042-1047.
9. MacMillan ML, Weisdorf DJ, Wagner JE, et al. Response of 443 patients
to steroids as primary therapy for acute graft-versus-host disease:
comparison of grading systems. Biol Blood Marrow Transplant.2002;8(7):387-394.
10. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late
deaths after allogeneic bone marrow transplantation. Late Effects
Working Committee of the International Bone Marrow Transplant Registry.N Engl J Med. 1999;341(1):14-21.
11. Cetin M, Yetgin S, Kara A, et al. Hyperglycemia, ketoacidosis and
other complications of L-asparaginase in children with acute
lymphoblastic leukemia. J Med. 1994;25(3-4):219-229.
12. Yoshida H, Imamura T, Saito AM, et al. Protracted Administration of
L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia
in Older Patients with Pediatric Acute Lymphoblastic Leukemia.PLoS One. 2015;10(8):e0136428.
13. Gatzioura I, Papakonstantinou E, Dimitriadou M, et al. Glucose
Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia
in Children With Acute Lymphoblastic Leukemia. Pediatr Blood
Cancer. 2016;63(7):1181-1184.
14. Petryk A, Kanakatti Shankar R, Giri N, et al. Endocrine disorders in
Fanconi anemia: recommendations for screening and treatment. J
Clin Endocrinol Metab. 2015;100(3):803-811.
15. Derr RL, Hsiao VC, Saudek CD. Antecedent hyperglycemia is associated
with an increased risk of neutropenic infections during bone marrow
transplantation. Diabetes Care. 2008;31(10):1972-1977.
16. Fuji S, Kim SW, Mori S, et al. Hyperglycemia during the neutropenic
period is associated with a poor outcome in patients undergoing
myeloablative allogeneic hematopoietic stem cell transplantation.Transplantation. 2007;84(7):814-820.
17. Garg R, Bhutani H, Alyea E, Pendergrass M. Hyperglycemia and length
of stay in patients hospitalized for bone marrow transplantation.Diabetes Care. 2007;30(4):993-994.
18. Pidala J, Kim J, Kharfan-Dabaja MA, et al. Dysglycemia following
glucocorticoid therapy for acute graft-versus-host disease adversely
affects transplantation outcomes. Biol Blood Marrow Transplant.2011;17(2):239-248.
19. Sheean P, Braunschweig C. The incidence and impact of dextrose dose
on hyperglycemia from parenteral nutrition (PN) exposure in
hematopoietic stem cell transplant (HSCT) recipients. JPEN J
Parenter Enteral Nutr. 2006;30(4):345-350.
20. de Souza Ferreira C, Araujo TH, Angelo ML, et al. Neutrophil
dysfunction induced by hyperglycemia: modulation of myeloperoxidase
activity. Cell Biochem Funct. 2012;30(7):604-610.
21. Gyurko R, Siqueira CC, Caldon N, Gao L, Kantarci A, Van Dyke TE.
Chronic hyperglycemia predisposes to exaggerated inflammatory response
and leukocyte dysfunction in Akita mice. J Immunol.2006;177(10):7250-7256.
22. Fuji S, Rovo A, Ohashi K, et al. How do I manage
hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.Bone Marrow Transplant. 2016.
23. Fuji S, Loffler J, Savani BN, Einsele H, Kapp M. Hyperglycemia as a
possible risk factor for mold infections-the potential preventative role
of intensified glucose control in allogeneic hematopoietic stem cell
transplantation. Bone Marrow Transplant. 2017;52(5):657-662.
24. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by
acute glucose fluctuations compared with sustained chronic hyperglycemia
in patients with type 2 diabetes. JAMA. 2006;295(14):1681-1687.
25. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A.
Intermittent high glucose enhances apoptosis related to oxidative stress
in human umbilical vein endothelial cells: the role of protein kinase C
and NAD(P)H-oxidase activation. Diabetes. 2003;52(11):2795-2804.
26. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent
high glucose enhances apoptosis in human umbilical vein endothelial
cells in culture. Am J Physiol Endocrinol Metab.2001;281(5):E924-930.
27. Stegenga ME, van der Crabben SN, Blumer RM, et al. Hyperglycemia
enhances coagulation and reduces neutrophil degranulation, whereas
hyperinsulinemia inhibits fibrinolysis during human endotoxemia.Blood. 2008;112(1):82-89.
28. Oldenborg PA, Sehlin J. Hyperglycemia in vitro attenuates
insulin-stimulated chemokinesis in normal human neutrophils. Role of
protein kinase C activation. J Leukoc Biol. 1999;65(5):635-640.
29. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia.Crit Care Clin. 2001;17(1):107-124.
30. Agus MS, Wypij D, Hirshberg EL, et al. Tight Glycemic Control in
Critically Ill Children. The New England journal of medicine.2017;376(8):729-741.
31. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional
glucose control in critically ill patients. The New England
journal of medicine. 2009;360(13):1283-1297.
32. Investigators N-SS, Finfer S, Liu B, et al. Hypoglycemia and risk of
death in critically ill patients. N Engl J Med.2012;367(12):1108-1118.
33. Agus MS, Asaro LA, Steil GM, et al. Tight glycemic control after
pediatric cardiac surgery in high-risk patient populations: a secondary
analysis of the safe pediatric euglycemia after cardiac surgery trial.Circulation. 2014;129(22):2297-2304.
34. De Block CE, Gios J, Verheyen N, et al. Randomized Evaluation of
Glycemic Control in the Medical Intensive Care Unit Using Real-Time
Continuous Glucose Monitoring (REGIMEN Trial). Diabetes Technol
Ther. 2015;17(12):889-898.
35. Smith AR, Majhail NS, MacMillan ML, et al. Hematopoietic cell
transplantation comorbidity index predicts transplantation outcomes in
pediatric patients. Blood. 2011;117(9):2728-2734.